Latest Headlines

  1. CloudLIMS’ New Kits Module Facilitates Sample Collection From Multiple Collection Sites For Clinical Studies

    CloudLIMS, a leading laboratory data management informatics provider, announces the release of a Kits module for its Laboratory Information Management System (LIMS), CloudLIMS

  2. Center For Gene And Cell Therapy Co-Founded By Miltenyi And ATLATL In Shanghai

    To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center for Gene and Cell Therapy

  3. Adam Equipment To Exhibit A Selection Of Lab Balances And Accessories At Forum Labo Paris

    Adam Equipment, a leading provider of professional balances worldwide, will present lab balances, scales and accessories at stand H77 at Forum Labo Paris from 26-28 March at Paris expo Porte de Versailles in France

  4. Asuragen Portfolio Expansion Continues With Launch Of AmplideX PCR/CE SMN1/2 Kit

    Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy-to-use products for complex testing in genetics and oncology, recently announced the launch of the AmplideX PCR/CE SMN1/2 Kit

  5. Have Microscope, Will Travel: New Tech Project Links Madison, Boston Scientists

    An invention designed to transform how and where high-powered research microscopes are deployed — and who gets to use them — will make its way from Madison this spring to the fertile biology labs of greater Boston

  6. Abbott Announces CE Mark For Alinity™ m Diagnostics System And Assays, The Latest In Molecular Technology, To Help Deliver Critical Test Results And Benefits To Patients

    Abbott (NYSE: ABT) announced today CE Mark for its Alinity™ m diagnostics system and assays

  7. U.S. Department Of Energy And Intel To Deliver First Exascale Supercomputer

    Intel Corporation and the U.S. Department of Energy (DOE) will deliver the first supercomputer with a performance of one exaFLOP in the United States

  8. CSI Laboratories Begins Offering VENTANA PD-L1 (SP142) Assay As Companion Diagnostic Test For Triple Negative Breast Cancer As A Result Of FDA Approval For TENCENTRIQ (atezolizumab)

    CSI Laboratories, a nationally renowned laboratory specializing in comprehensive cancer diagnostics, recently announced that it has added the newly approved VENTANA PD-L1 (SP142) Assay as a companion diagnostic test for use in selecting triple-negative breast cancer (TNBC) patients for TENCENTRIQ (atezolizumab)

  9. Bruker Is Three-Time Winner Of The iF DESIGN AWARD 2019

    Bruker has been awarded the iF DESIGN AWARD for three different products ranking them among the most innovative instrumentation designers

  10. Hardy Diagnostics And EliTech Form Strategic Distribution Partnership

    Hardy Diagnostics, an ISO 13485 certified manufacturer and distributor of medical devices for microbiological procedures, has formed a partnership with EliTechGroup. Hardy Diagnostics is now an authorized distributor of EliTech's MYCOFAST US, a rapid system to detect, enumerate and identify genital Mycoplasma hominis and Ureaplasma urealyticum